can008
mAbexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2016 (NCT02853565)
Timeline
Indications
Studied for
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- can008
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05447195 | Phase 2 | Oct 10, 2021 | CANbridge Life Sciences Ltd., Capital Medical University |
| NCT03746288 | Phase 2 | Nov 20, 2018 | CANbridge Life Sciences Ltd. |
| NCT02853565 | Phase 1 | Aug 1, 2016 | CANbridge Life Sciences Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CANbridge Life Sciences Ltd. | For profit | 3 | 3 | 2 | 2016 |
| Capital Medical University | Academic/Hospital | 1 | 0 | 1 | 2021 |
2 organizations
Page 1 / 1